drugset / Trial / NCT06754332

The Study of Human Chorionic Gonadotropin (HCG) Activating the Dormant Follicles .

NCT06754332

Non-randomizedSequentialOpen-labelTreatment

Summary

This project aims to activate dormant follicles in patients with premature ovarian insufficiency by injecting human chorionic gonadotropin (hCG) to explore the feasibility of a treatment plan that stimulates the growth of dormant follicles, not visible to the naked eye, to antral follicles visible under ultrasound, without visible follicle growth. The project also seeks to enable patients to conceive offspring carrying their own genetic material through in vitro fertilization (IVF) technology.

Timeline

Start
2025-04-01
Primary completion
2028-04-01
Completion
2029-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic 10000 iu Intramuscular